検索結果 - Santos Carvajal‐Gonzalez

  • 検索結果 1 - 5 結果 / 5
結果の絞り込み
  1. 1
    Pharmacokinetics and pharmacodynamics of PF‐05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects

    Pharmacokinetics and pharmacodynamics of PF‐05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects 著者: William S. Denney, Gabriele E. Sonnenberg, Santos Carvajal‐Gonzalez, Theresa Tuthill, V. Margaret Jackson

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study

    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study 著者: Arthur Bergman, Santos Carvajal‐Gonzalez, Sanela Tarabar, Aditi R. Saxena, William P. Esler, Neeta B. Amin

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis

    Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis 著者: Neeta B. Amin, Santos Carvajal‐Gonzalez, Julie J. Purkal, Tong Zhu, Collin Crowley, Sylvie Perez, Kristin Chidsey, Albert M. Kim, Bryan Goodwin

    出版事項 2019
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems

    Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems 著者: Trenton T. Ross, Collin Crowley, Kenneth L. Kelly, Anthony Rinaldi, David A. Beebe, Matthew P. Lech, Robert V. Martinez, Santos Carvajal‐Gonzalez, Magalie Boucher, Dinesh Hirenallur‐Shanthappa, Jeffrey Morin, Alan Opsahl, Sarah Regina Vargas, Kendra K. Bence, Jeffrey A. Pfefferkorn, William P. Esler

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Decreasing the Rate of Metabolic Ketone Reduction in the Discovery of a Clinical Acetyl-CoA Carboxylase Inhibitor for the Treatment of Diabetes

    Decreasing the Rate of Metabolic Ketone Reduction in the Discovery of a Clinical Acetyl-CoA Carboxylase Inhibitor for the Treatment of Diabetes 著者: David A. Griffith, Daniel W. Kung, William P. Esler, Paul A. Amor, Scott W. Bagley, Carine Beysen, Santos Carvajal‐Gonzalez, Shawn D. Doran, Chris Limberakis, Alan M. Mathiowetz, Kirk McPherson, David A. Price, Éric Ravussin, Gabriele E. Sonnenberg, James A. Southers, Laurel J. Sweet, Scott Turner, F.F. Vajdos

    出版事項 2014
    全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: